HCA Healthcare Inc header image

HCA Healthcare Inc

HCA

Equity

ISIN null / Valor 11321027

New York Stock Exchange, Inc (2025-10-17)
USD 426.16+1.56%

HCA Healthcare Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

HCA Healthcare Inc is a for-profit operator of healthcare facilities, including hospitals and surgery centers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (09.09.2025):

HCA Healthcare Inc reported strong financial results for the second quarter of 2025, demonstrating significant growth in revenues, net income, and earnings per share compared to the same period in the previous year.

Revenue Growth

Revenues increased by 6.4 percent, reaching $18.605 billion in Q2 2025 compared to $17.492 billion in Q2 2024.

Net Income and Earnings Per Share

Net income attributable to HCA Healthcare Inc rose by 13.1 percent to $1.653 billion. Diluted earnings per share increased 23.5 percent to $6.83, while adjusted diluted earnings per share grew by 24.4 percent to $6.84.

Adjusted EBITDA and Cash Flow

Adjusted EBITDA saw an 8.4 percent increase, totaling $3.849 billion. Cash flows from operating activities more than doubled, reaching $4.210 billion compared to $1.971 billion in Q2 2024.

Admissions and Surgery Metrics

Same facility admissions grew by 1.8 percent, and same facility equivalent admissions rose by 1.7 percent. Same facility revenue per equivalent admission increased by 4.0 percent.

Dividend Declaration

HCA Healthcare Inc’s Board of Directors declared a quarterly cash dividend of $0.72 per share, to be paid on September 30, 2025.

Guidance Update

The company updated its 2025 guidance, revising revenue projections to $74.00-$76.00 billion and net income to $6.11-$6.48 billion, reflecting continued optimism in its financial outlook.

Summarized from source with an LLMView Source

Key figures

4.84%1Y
107%3Y
215%5Y

Performance

28.9%1Y
25.8%3Y
30.2%5Y

Volatility

Market cap

99719 M

Market cap (USD)

Daily traded volume (Shares)

1,034,500

Daily traded volume (Shares)

1 day high/low

303 / 296.92

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 146.78
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%SEK 29.34
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.51%EUR 62.52
Patterson Companies Inc
Patterson Companies Inc Patterson Companies Inc Valor: 1896660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 31.33
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.54%USD 36.81
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 54.92
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%USD 35.27
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 19.92
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CAD 10.89
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.70%USD 15.06